Plantech is a cutting-edge biotechnology company specializing in plant-based recombinant protein and small molecule programs. Leveraging our expertise in plant-based protein production technologies, advanced drug discovery and development platforms, and innovative bio-stimulant solutions, we are committed to delivering sustainable advancements across various industries.

In the realm of Plant-based Recombinant Protein Production, our groundbreaking Production of Allergenic Proteins project has reached a significant milestone with the successful completion of its Research and Development (R&D) phase. These efforts have culminated in the market launch of innovative products, setting a new benchmark in the industry.

In our dynamic Plant-based Small Molecule Programs, the Bio-stimulant-based Platform is at the forefront of innovation. Our commitment is evident in the ongoing exploration and development of innovative bio-stimulant active ingredients, coupled with the formulation development for unique combinations of these ingredients.

Our drug discovery initiatives target metabolic disorders, including diabetes, obesity, hyperuricemia, and NAFLD/NASH (non-alcoholic fatty liver disease/non-alcoholic steatohepatitis). These programs aim to develop therapies that address the underlying mechanisms and contributing factors of these conditions, advancing their prevention, management, and treatment.

The parent company SignalChem Lifesciences Corporation (SLC) is a cutting-edge biotech company with unique protein engineering technologies and innovative drug discovery platforms. (Learn More)